Why did 1ST.AX stock spike pre-market today?

1ST.AX stock jumped due to heavy volume and sector interest in healthcare marketplaces; there was no single company release. Retail flows and broader healthcare headlines likely fueled buying in this ASX microcap.

What is Meyka AI's view on 1ST.AX stock?

Meyka AI rates 1ST.AX at **61.55/100** (Grade B, HOLD) and models a one-year price of **A$0.00718**, noting risks from negative EPS and tight liquidity. This is a model projection, not investment advice.

What are the key financial risks for 1ST.AX stock?

Key risks include negative operating margins, **EPS -0.01**, weak current ratio **0.83**, and high payable days that pressure working capital; these raise execution and funding risk for the ASX-listed company.

Should traders buy 1ST.AX stock on the pre-market move?

Traders may consider short-term momentum setups given the **22.22%** surge and high relative volume, but should size positions for volatility and confirm follow-through at market open on ASX.

AU Stocks

1ST.AX jumps 22.22% in ASX pre-market 14 Jan 2026: heavy volume hints momentum

ByDanny Kontos January 14, 2026

The 1ST.AX stock jumped 22.22% in ASX pre-market trading on 14 Jan 2026, trading at A$0.011 after an earlier close of A$0.009. Volume spiked to 2,075,140 shares versus an average of 678,621, giving the move strong market participation. The rise follows improving short-term averages and sector attention in healthcare information services. We examine the drivers, valuation, Meyka AI grade, and a model forecast to frame the trade setup.